2,3-bis(4-hydroxyphenyl)-propionitrile and Adrenal Cancer

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Adrenal Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, JW; Fishman, LM; Perez-Stable, C; Prieto, LM	1

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Adrenal Cancer

Article	Year
High dose 17 beta-estradiol and the alpha-estrogen agonist PPT trigger apoptosis in human adrenal carcinoma cells but the beta-estrogen agonist DPN does not. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2008, Volume: 40, Issue:5 Topics: Adrenal Gland Neoplasms; Apoptosis; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Estradiol; Estrogens; Flow Cytometry; Humans; Nitriles; Phenols; Pyrazoles; Receptors, Estrogen	2008

Article

Year

High dose 17 beta-estradiol and the alpha-estrogen agonist PPT trigger apoptosis in human adrenal carcinoma cells but the beta-estrogen agonist DPN does not.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2008, Volume: 40, Issue:5

Topics: Adrenal Gland Neoplasms; Apoptosis; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Estradiol; Estrogens; Flow Cytometry; Humans; Nitriles; Phenols; Pyrazoles; Receptors, Estrogen

2008